https://www.taxtmi.com/news?id=58773 Board approval authorised a preferential issue of fully convertible equity warrants, including promoter and strategic institutional participation, to raise capital by issuance of up to 44,50,000 warrants at the prescribed issue price convertible into equity under the approved terms. Proceeds are earmarked for organic and inorganic expansion-new and upgraded diagnostic laboratories, infrastructure enhancements, and working capital-and are coupled with an exclusive strategic partnership to establish diagnostic centres across the partner's hospitals and clinics nationwide. en-us Tue, 14 Oct 2025 16:46:03 +0530 Tue, 14 Oct 2025 16:46:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=58773 Board approval authorised a preferential issue of fully convertible equity warrants, including promoter and strategic institutional participation, to raise capital by issuance of up to 44,50,000 warrants at the prescribed issue price convertible into equity under the approved terms. Proceeds are earmarked for organic and inorganic expansion-new and upgraded diagnostic laboratories, infrastructure enhancements, and working capital-and are coupled with an exclusive strategic partnership to establish diagnostic centres across the partner's hospitals and clinics nationwide. News - Tue, 14 Oct 2025 16:46:03 +0530 https://www.taxtmi.com/news?id=58773